Dr. Reddy's Laboratories is mentioned as a top pharma company for which Onesource Specialty Pharma acts as a manufacturing partner.
Source Post
This reel discusses a Bangalore-based specialty CDMO company, Onesource Specialty Pharma, poised to benefit...
Next Big Thing by AvaniApr 22, 2026
This reel discusses a Bangalore-based specialty CDMO company, Onesource Specialty Pharma, poised to benefit from the global GLP-1 drug boom. The company manufactures complex injectables and is a partner for major pharma companies, including Dr. Reddy's Laboratories. Despite current losses and some delays, the company has strong revenue growth projections and a robust demand outlook.
Linked Mentions
Tickers discussed in this post
Onesource Specialty Pharma is a promising investment due to its role in the growing GLP-1 market, strong manufacturing capabilities, and significant revenue growth potential.
Linked Signals
Tracked calls opened from this post
ONESOURCE.BO
buy opened Apr 22, 2026
+4.75%